Big Moving Stock keep track of the biggest moving stocks in the market.


Nasdaq: GOOG NFLX AMZN BIIB IBB TSLA ALXN WYNN AMGN GMCR COST SIAL AAPL Z VRTX MNST CELG SLXP WDC
Nyse: ACT V LNKD AGN IVV LMT SPG PXD FDX IBM MMM CMI APD GD TWC NOC HUM BA PH PX
New Highs: BLK V SHW PPG IVV WHR RL FDX BCR AMGN MMM FLT APD GD COST NOC PH AMP BDX FFIV

The Hot Industries

Medical Instruments & Supplies 2
Asset Management 2
Specialty Chemicals 2

The Hot Sectors

Industrial Goods 4
Healthcare 3
Financial 3

CELG Stock Chart


CELG
Analyze

Sector:

Healthcare
Daily

Industry:

Biotechnology
Weekly

Employees:

5,100
Monthly

Website:

http://www.celgene.com

CELG Celgene Corporation

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. The company’s commercial stage products include REVLIMID, an oral immunomodulatory drug for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, as well as acute myeloid leukemia (AML); ABRAXANE, a solvent-free chemotherapy product for the treatment of breast, non-small cell lung, pancreatic, and gastric cancers; and POMALYST/IMNOVID for the treatment of multiple myeloma. Its commercial stage products also comprise THALOMID for the patients with multiple myeloma and for the acute treatment of the cutaneous manifestations of erythema nodosum leprosum; ISTODAX to treat cutaneous T-cell lymphoma; and FOCALIN, FOCALIN XR, and RITALIN LA products. The company’s pre clinical and clinical stage products consist of OTEZLA for the treatment of psoriatic arthritis, psoriasis, and ankylosing spondylitis; CC-122 and CC-220 to treat hematological and solid tumor cancers; cellular therapies, such as PDA-001 and PDA-002 for Crohn’s and peripheral arterial diseases; CC-486, to treat MDS, AML, and solid tumors; Sotatercept and ACE-536 for the treatment of anemia in patients with rare blood disorders; CC-223 and CC-115 for lymphomas, hepatocellular, and prostate cancers; and CC-292 for the treatment of chronic lymphocytic leukemia and lymphomas. It has strategic drug discovery collaboration with Abide Therapeutics to enhance the treatment paradigm for patients with immune disorders. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.

favicon

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

21 Nov 2014, 5:28 pmSearch Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK ( TheStreet) -- "Their weakness is not our weakness," Jim Cramer told his Mad Money  viewers Friday. The U.S. economy is a lot stronger than Europe, China and Japan, and that means sticking with what's working right here in the good old USA. Cramer said he is still a fan of stocks ...
favicon

Cramer: Agios Pharmaceuticals' Leukemia Drug Pushing Stock 'Much Higher'

19 Nov 2014, 9:44 am  NEW YORK (TheStreet) -- Shares of Agios Pharmaceuticals  jumped 12.5% Wednesday after the company reported positive Phase 1 clinical data for its leukemia drug.  The stock has more than doubled since July and has tripled since February, but the gains are not done, according to TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio.  Must Read: Warren Buffett's Top 10 Dividend ...
favicon

Jim Cramer's Top Stock Picks: MMM UNH CELG AMZN HD ALKS PPG

19 Nov 2014, 4:13 amSearch Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- Here are some of the hot stocks Jim Cramer talked about on Tuesday's Mad Money on CNBC: MMM data by YCharts 3M , UnitedHealth Group and Celgene : Cramer said he remains a fan of all three of these stocks as they continue to power higher. AMZN data by YCharts Amazon.com ...
favicon

Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene

14 Nov 2014, 7:27 amLONDON, November 14, 2014 /PRNewswire/ -- Investor-Edge has initiated coverage on the following equities: Gilead Sciences Inc. (NASDAQ: GILD), MannKind Corporation (NASDAQ: MNKD), ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA), iBio Inc. (NYSE MKT: IBIO), and Celgene Corporation (NASDAQ:...
favicon

Which Mega Caps Are Buying Their Own Stock?

13 Nov 2014, 1:51 pmThe graph below was produced by  Capital Market Labs . Stock repurchases have been at or near all-time highs for a year now and some pundits have questioned if a part of the bull market run has been artificially ...
favicon

Critical Alerts For Alibaba, Bloomin' Brands, VoxelJet, 51job and Celgene Released By InvestorsObserver

5 Nov 2014, 7:44 amCHICAGO, Nov. 5, 2014 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BABA, BLMN, VJET, JOBS and CELG. To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. (Note:...
favicon

Stock picks: 14 trades in 73 seconds

31 Oct 2014, 4:25 pmThe "Fast Money" traders share their final trades of the day.
favicon

Jim Cramer's Top Stock Picks: CELG REGN GILD BIIB TTWO CRL FLEX

31 Oct 2014, 4:28 amSearch Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- Here are some of the hot stocks Jim Cramer talked about on Thursday's Mad Money on CNBC: CELG data by YCharts Celgene , Regeneron , Gilead Sciences and Biogen Idec : Cramer said his "four hoursemen" of biotech continue to march on and remain terrific investments. TTWO ...
favicon

Celgene: Three cheers for being alive

27 Oct 2014, 10:55 amCelgene: Three cheers for being alive
favicon

Jim Cramer's Top Stock Picks: CELG FTK BA JAH AVT

24 Oct 2014, 4:28 amSearch Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- Here are some of the hot stocks Jim Cramer talked about on Thursday's Mad Money on CNBC: CELG data by YCharts Celgene : Cramer said this biotech had a lot of positive things to say when itareleased earnings and remains one of his favorites in the group. FTK data by ...